Loss or downregulation of RKIP has been observed in various cancers, including prostate, breast, and hepatocellular carcinoma, where it correlates with enhanced metastatic potential and poor prognosis, underscoring its role as a metastasis suppressor [54,55,56,57]. The gene discussed is PEBP1; the disease is hepatocellular carcinoma.